Locoregional Therapy for Patients With Hepatocellular Carcinoma

. 2015 Oct;11(10):698-700.

Affiliations

Jean-Francois H Geschwind. Gastroenterol Hepatol (N Y). 2015 Oct.

. 2015 Oct;11(10):698-700.

¹ Professor of Radiology and Oncology Chairman, Department of Diagnostic Radiology Yale School of Medicine New Haven, Connecticut.

No abstract available

Cited by

Contrast-enhanced Ultrasound Identifies Patent Feeding Vessels in Transarterial Chemoembolization Patients With Residual Tumor Vascularity.
Wessner CE, Shaw CM, Stanczak M, Forsberg F, Lyshchik A, Tan A, Eisenbrey JR. Wessner CE, et al. Ultrasound Q. 2020 Sep;36(3):218-223. doi: 10.1097/RUQ.0000000000000513. Ultrasound Q. 2020. PMID: 32890324 Free PMC article. Review.
Prognostic analysis of hepatocellular carcinoma on the background of liver cirrhosis via contrast-enhanced ultrasound and pathology.
He Y, Liu F, Mou S, Li Q, Wang S. He Y, et al. Oncol Lett. 2018 Mar;15(3):3746-3752. doi: 10.3892/ol.2018.7792. Epub 2018 Jan 12. Oncol Lett. 2018. PMID: 29467891 Free PMC article.
LI-RADS 2017: An update.
Kielar AZ, Chernyak V, Bashir MR, Do RK, Fowler KJ, Mitchell DG, Cerny M, Elsayes KM, Santillan C, Kamaya A, Kono Y, Sirlin CB, Tang A. Kielar AZ, et al. J Magn Reson Imaging. 2018 Jun;47(6):1459-1474. doi: 10.1002/jmri.26027. Epub 2018 Apr 6. J Magn Reson Imaging. 2018. PMID: 29626376 Free PMC article. Review.

1. Chapiro J, Duran R, Geschwind JF. Combination of intra-arterial therapies and sorafenib: is there a clinical benefit? Radiol Med. 20l4;119(7):476–482. - PubMed
1. Chapiro J, Geschwind JF. Science to practice: the changing face of local tumor therapies—do we have to think systemically when treating cancer locally? Radiology. 2015;276(2):315–317. - PMC - PubMed
1. Chapiro J, Tacher V, Geschwind JF. Intraarterial therapies for primary liver cancer: state of the art. Expert Rev Anticancer Ther. 2013;13(10):1157–1167. - PubMed
1. Cheng AL, Amarapurkar D, Chao Y, et al. Re-evaluating transarterial chemoembolization for the treatment of hepatocellular carcinoma: consensus recommendations and review by an international expert panel. Liver Int. 2014;34(2):174–183. - PubMed
1. Cosgrove DP, Reyes DK, Pawlik TM, Feng AL, Kamel IR, Geschwind JF. Open-label single-arm phase II trial of sorafenib therapy with drug-eluting bead transarterial chemoembolization in patients with unresectable hepatocellular carcinoma: clinical results [published online June 11, 2015] Radiology. doi:10.1148/radiol.2015142481. - PubMed